Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 1.41 M1.02 M1.6 M1.13 M1.64 M1.24 M 5.61 M Research & development 1.64 M1.88 M1.77 M1.53 M361 K407 K 4.07 M Operating income -3.05 M-2.9 M-3.37 M-2.66 M-2 M-1.65 M -9.68 M Non-Operating Income, Total —————— — Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses —————— — Unusual income/expense —————— — Pretax income -3.05 M-2.9 M-3.37 M-2.66 M-2 M-1.65 M -9.68 M Equity in earnings —————— — Taxes ———3 000—— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -3.05 M-2.89 M-3.36 M-2.66 M-2 M-1.64 M -9.66 M Discontinued operations —————— — Net income -3.05 M-2.89 M-3.36 M-2.66 M-2 M-1.64 M -9.66 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders -3.05 M-2.89 M-3.36 M-2.66 M-2 M-1.64 M -9.66 M Basic earnings per share (Basic EPS) -162.4-36.68-35.84113.06-1.61-0.91 74.7 Diluted earnings per share (Diluted EPS) -162.4-36.68-35.84113.06-1.61-0.91 74.7 Average basic shares outstanding 18.77 K78.75 K93.62 K98.16 K1.24 M1.8 M — Diluted shares outstanding 18.77 K78.75 K93.62 K98.16 K1.24 M1.8 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 1 0001 0001 0001 0001 0000 3 000